Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Rheumatology International
|
March 13, 2016
Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia
Nemanja Damjanov, Waleed Al Shehhi, Feng Huang, et al.
Breast (Edinburgh, Scotland)
|
August 13, 2021
Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2
Karen Gelmon, Janice M Walshe, Reshma Mahtani, et al.
Journal of the American Academy of Dermatology
|
August 29, 2013
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J Mease, Dafna D Gladman, Kim A Papp, et al.
Rheumatology and Therapy
|
May 16, 2018
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses
Vibeke Strand, Arthur Kavanaugh, Alan J Kivitz, et al.
Breast Cancer Research : BCR
|
March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Johannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Seminars in Arthritis and Rheumatism
|
September 5, 2018
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
Alan J Kivitz, Stanley Cohen, Edward Keystone, et al.
The Journal of Rheumatology
|
November 17, 2017
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies
Christina Charles-Schoeman, Désirée van der Heijde, Gerd R Burmester, et al.
United European Gastroenterology Journal
|
February 1, 2025
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
Anita Afzali, Miguel Regueiro, Andres J Yarur, et al.
Clinical Rheumatology
|
May 14, 2013
Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study
Karel Pavelka, Zoltan Szekanecz, Nemanja Damjanov, et al.
Inflammatory Bowel Diseases
|
March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Bruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Rheumatology International
|
March 13, 2016
Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia
Nemanja Damjanov, Waleed Al Shehhi, Feng Huang, et al.
Breast (Edinburgh, Scotland)
|
August 13, 2021
Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2
Karen Gelmon, Janice M Walshe, Reshma Mahtani, et al.
Journal of the American Academy of Dermatology
|
August 29, 2013
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J Mease, Dafna D Gladman, Kim A Papp, et al.
Rheumatology and Therapy
|
May 16, 2018
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses
Vibeke Strand, Arthur Kavanaugh, Alan J Kivitz, et al.
Breast Cancer Research : BCR
|
March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies
Johannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Seminars in Arthritis and Rheumatism
|
September 5, 2018
A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
Alan J Kivitz, Stanley Cohen, Edward Keystone, et al.
The Journal of Rheumatology
|
November 17, 2017
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies
Christina Charles-Schoeman, Désirée van der Heijde, Gerd R Burmester, et al.
United European Gastroenterology Journal
|
February 1, 2025
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
Anita Afzali, Miguel Regueiro, Andres J Yarur, et al.
Clinical Rheumatology
|
May 14, 2013
Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study
Karel Pavelka, Zoltan Szekanecz, Nemanja Damjanov, et al.
Inflammatory Bowel Diseases
|
March 4, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Bruce E Sands, Marla C Dubinsky, Paulo G Kotze, et al.
Page
of 5